Tryptophan Hydroxlase 1 (TPH1) Promoter Genotype but not Serum Serotonin Levels Identify IBS-D Patients More Likely to Benefit from the Low Fodmap Diet

MLA

Dennis Madriaga, et al. “Tryptophan Hydroxlase 1 (TPH1) Promoter Genotype but Not Serum Serotonin Levels Identify IBS-D Patients More Likely to Benefit from the Low Fodmap Diet.” Gastroenterology, vol. 152, Apr. 2017, p. S69. EBSCOhost, https://doi.org/10.1016/s0016-5085(17)30585-1.

APA

Dennis Madriaga, Shanti Eswaran, Fabiyola Selvaraj, William D. Chey, Fred Princen, Amanda Photenhauer, Kenya Jackson, & Juanita L. Merchant. (2017). Tryptophan Hydroxlase 1 (TPH1) Promoter Genotype but not Serum Serotonin Levels Identify IBS-D Patients More Likely to Benefit from the Low Fodmap Diet. Gastroenterology, 152, S69. https://doi.org/10.1016/s0016-5085(17)30585-1

Chicago

Dennis Madriaga, Shanti Eswaran, Fabiyola Selvaraj, William D. Chey, Fred Princen, Amanda Photenhauer, Kenya Jackson, and Juanita L. Merchant. 2017. “Tryptophan Hydroxlase 1 (TPH1) Promoter Genotype but Not Serum Serotonin Levels Identify IBS-D Patients More Likely to Benefit from the Low Fodmap Diet.” Gastroenterology 152 (April): S69. doi:10.1016/s0016-5085(17)30585-1.